Caro, J. Jaime
J. Jaime Caro, MDCM, FRCPC, FACP
Philadelphia, PA 19107
(215) 923-7583 fax
MDCM, McGill University (Canada)
Internal Medicine, Royal Victoria Hospital (Canada)
Epidemiology and Biostatistics, McGill University (Canada)
Clinical Research, Royal Victoria Hospital (Canada)
Lecturer, Jefferson College of Population Health
Research & Practice Interests
Health Technology Assessment
Simulation for Economic Evaluation
Dr. Jaime Caro is Chief Scientist at Evidera where he focuses on developing and applying novel techniques in modeling, health economics, comparative effectiveness, epidemiology and outcomes research. Dr. Caro trained at McGill University, where he practiced internal medicine and continues as Adjunct Professor of Medicine and Adjunct Professor of Epidemiology & Biostatistics. Dr. Caro also teaches at the Thomas Jefferson University College of Population Health and the Massachusetts College of Pharmacy & Health Sciences.
Dr. Caro continues to pioneer new methodologies in health economic modeling, discrete event simulation to model diseases and their treatment, Simulated Treatment Comparison to provide comparative effectiveness information in the absence of head-to-head trials, simulation techniques to make post-marketing registries more feasible and efficient and health technology assessments.
Most Recent Peer-Reviewed Publications
- Pharmacoeconomics, Outcomes Research, Health Technology Assessment, Comparative Effectiveness, Patient Centered Outcomes Research in Latin America 2016: brief update
- Response to Letter to the Editor Regarding Discretely Integrated Condition Event Simulation for Pharmacoeconomics
- Discretely Integrated Condition Event (DICE) Simulation for Pharmacoeconomics
- Advantages and disadvantages of discrete-event simulation for health economic analyses
- Erratum: A modeling study questionnaire to assess study relevance and credibility to inform health care decision making: An ISPOR-AMCP-NPC good practice task force report (Value Health (2014) 17:2 (174-182))
- Brief Latin American Update: One More ViHRI Annual Issue, and Another Exciting Biennial ISPOR Conference
- Communicating the parameter uncertainty in the IQWiG efficiency frontier to decision-makers
- Psst, have i got a model for you...
- What Is Insufficient about Validation?
- Introducing the New Value in Health Regional Issues Journal: The Latin America Region Edition
- One small step for latin America, one more leap for value in health regional issues
- The importance of patient-reported outcomes: A call for their comprehensive integration in cardiovascular clinical trials
- Decision-Analytic Models: Current Methodological Challenges
- Assessing the value of healthcare interventions using multi-criteria decision analysis: A review of the literature
- Questionnaire to assess relevance and credibility of modeling studies for informing health care decision making: An ISPOR-AMCP-NPC good practice task force report
- Budget impact analysis - Principles of good practice: Report of the ISPOR 2012 budget impact analysis good practice II task force
- ISPOR-SMDM task force's recommendations for good modeling practices - Reply to letter to the editor by Corro Ramos
- Lopinavir/ritonavir versus darunavir plus ritonavir for HIV infection: A cost-effectiveness analysis for the United States
- Treating acetaminophen overdose: Thresholds, costs and uncertainties
- How relevant is cost-effectiveness anyway?